Get the Stockscreener App
3.94
1.75%
-0.07
Evolent Health Inc stock is traded at $3.94, with a volume of 2.24M.
It is down -1.75% in the last 24 hours and down -37.95% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$4.01
Open:
$4
24h Volume:
2.24M
Relative Volume:
0.63
Market Cap:
$439.71M
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-4.1915
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
-6.19%
1M Performance:
-37.95%
6M Performance:
-51.89%
1Y Performance:
-64.98%
1-Day Range:
$3.9245
$4.145
1-Week Range:
$3.79
$4.23
52-Week Range:
$3.495
$12.98
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.94 | 447.52M | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
242.00 | 39.83B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.66 | 13.58B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.93 | 9.66B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.51 | 8.17B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.35 | 6.77B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Is Evolent Health Inc Class stock testing key support2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser
Will Evolent Health Inc Class stock justify high valuationProduct Launch & Reliable Price Action Trade Plans - Newser
What market sentiment indicators show for Evolent Health Inc Class stockEarnings Risk Report & Daily Oversold Stock Bounce Ideas - Newser
Can Evolent Health Inc. stock weather global recessionEarnings Risk Summary & Reliable Trade Execution Plans - Newser
How Evolent Health Inc. (9EH) stock expands through international marketsJuly 2025 Setups & Entry Point Confirmation Signals - Newser
Will Evolent Health Inc Class stock outperform foreign stocksEntry Point & Low Risk Entry Point Tips - Newser
How geopolitical risks impact Evolent Health Inc Class stockPortfolio Gains Report & Verified Stock Trade Ideas - Newser
Piper Sandler slashes Evolent Health stock price target to $6 from $18 - Investing.com Canada
Evolent Health Appoints Jill Smith to Board - TipRanks
Evolent Health (EVH) names new independent director and reiterates Q4 2025 guidance - Stock Titan
Is Evolent Health Inc. (9EH) stock a buy for dividend portfoliosJuly 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Is Evolent Health Inc. stock a buy before product launchesMarket Activity Summary & Consistent Profit Focused Trading Strategies - Newser
Geode Capital Management LLC Has $30.04 Million Stock Position in Evolent Health, Inc $EVH - MarketBeat
Investment Report: What hedge fund activity signals for Evolent Health Inc. stockJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - BỘ NỘI VỤ
Responsive Playbooks and the EVH Inflection - news.stocktradersdaily.com
How the Narrative for Evolent Health Is Shifting After Analyst Revisions and New Developments - Yahoo Finance
Hopeful Week For Insiders Who Bought US$1.38m Of Evolent Health Stock - simplywall.st
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know - The Globe and Mail
Evolent Health Secures Upgrades Amid AI Growth Push - StocksToTrade
Evolent Health’s Stock Surges Amidst Strategic Upgrades and Market Optimism - StocksToTrade
Evolent Health Gains Momentum as Analysts Upgrade Ratings - timothysykes.com
Evolent Health Gains Momentum with Strategic AI Initiatives - timothysykes.com
Evolent Health Stock Gains Momentum Amid Strategic Moves - StocksToTrade
Citigroup Has Lowered Expectations for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Evolent Health Sees Uptrend with Analyst Upgrades and AI Initiatives - StocksToTrade
Evolent Health, American Oncology Network Partner to Streamline Cancer Care - MSN
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know - Yahoo Finance
Evolent Health (EVH): Citigroup Adjusts Price Target While Maint - GuruFocus
Can Evolent Health Inc. (9EH) stock ride next bull market cycleJuly 2025 Volume & Technical Entry and Exit Tips - newser.com
Evolent Health Inc (9EH.SG) Insider Ownership & Holdings - Yahoo! Finance Canada
Evolent Health (EVH) Price Target Decreased by 28.65% to 11.40 - MSN
Evolent Health (NYSE:EVH) Director Acquires $38,200.00 in Stock - MarketBeat
TD Cowen reaffirms Buy rating on Evolent Health stock amid selloff - Investing.com Canada
Stocks making big moves yesterday: Cogent, Wix, WESCO, LGI Homes, and Evolent Health - The Globe and Mail
Evolent Health: Overly Pessimistic Valuation Presents a Buy Opportunity Amidst Exaggerated Concerns - TipRanks
Can Evolent Health Inc. (9EH) stock hold up in economic slowdown2025 AllTime Highs & Daily Volume Surge Signals - newser.com
Engaged Capital takes new position in BlackLine, Cognex, lowers stake in Evolent Health in Q3 moves - MSN
Can Evolent Health Inc. (9EH) stock sustain revenue momentumPortfolio Performance Report & AI Based Trade Execution Alerts - newser.com
Applying Wyckoff theory to Evolent Health Inc. stockTrade Risk Assessment & Daily Chart Pattern Signals - newser.com
Is Evolent Health Inc. stock oversold or undervaluedJuly 2025 Selloffs & Free High Return Stock Watch Alerts - newser.com
Is Evolent Health Inc. stock positioned well for digital economyEarnings Risk Summary & Advanced Technical Analysis Signals - newser.com
Why Evolent Health Inc. stock is popular among millennials - newser.com
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.88%
0.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):